+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Roche Diagnostics Ltd. - logo

Founded in Basel, Switzerland in 1896, Roche produces innovative medicines and diagnostic tests for the early detection, prevention, diagnosis and treatment of diseases including oncology, rheumatology, virology, transplantation, diabetes and immunology. They are the world’s leading biotech company and have been at the forefront of cancer research and treatment for more than 50 years, in addition to being the leading provider of in vitro diagnostics.

Adoptive Cell Therapy for Cancer Treatment Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Adoptive Cell Therapy for Cancer Treatment Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • March 2022
  • 84 Pages
  • Global
From
Autoinjectors: Intellectual Property Landscape, Featuring Historical and Contemporary Patent Filing Trends, Prior Art Search Expressions, Patent Valuation Analysis, Patentability, Freedom to Operate, Pockets of Innovation, Existing White Spaces, and Claims Analysis - Product Thumbnail Image

Autoinjectors: Intellectual Property Landscape, Featuring Historical and Contemporary Patent Filing Trends, Prior Art Search Expressions, Patent Valuation Analysis, Patentability, Freedom to Operate, Pockets of Innovation, Existing White Spaces, and Claims Analysis

  • Report
  • January 2023
  • 205 Pages
  • Global
From
Glucokinase Activators - Pipeline Insight, 2025 - Product Thumbnail Image

Glucokinase Activators - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Idiopathic Pulmonary Fibrosis - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Thumbnail Image

Idiopathic Pulmonary Fibrosis - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • May 2025
  • 110 Pages
  • Global
From
Cancer Immunotherapy Market 2025-2029 - Forecasts for Immuno-Oncology Therapeutics by Therapy, Cancer and Customer, with Executive and Consultant Guides - Product Thumbnail Image

Cancer Immunotherapy Market 2025-2029 - Forecasts for Immuno-Oncology Therapeutics by Therapy, Cancer and Customer, with Executive and Consultant Guides

  • Report
  • July 2025
  • 262 Pages
  • Global
From
Renal Anemia Therapeutics Market 2025-2029 - Product Thumbnail Image

Renal Anemia Therapeutics Market 2025-2029

  • Report
  • June 2025
  • 210 Pages
  • Global
From
2024 US Blood Typing, Grouping and Infectious Disease NAT Screening Market - Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays - Product Thumbnail Image

2024 US Blood Typing, Grouping and Infectious Disease NAT Screening Market - Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays

  • Report
  • May 2024
  • United States
From
2024 UK Blood Typing, Grouping and Infectious Disease NAT Screening Market - Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays - Product Thumbnail Image

2024 UK Blood Typing, Grouping and Infectious Disease NAT Screening Market - Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays

  • Report
  • May 2024
  • United Kingdom
From
2024 Spain Blood Typing, Grouping and Infectious Disease NAT Screening Market - Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays - Product Thumbnail Image

2024 Spain Blood Typing, Grouping and Infectious Disease NAT Screening Market - Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays

  • Report
  • May 2024
  • Spain
From
2024 Japan Blood Typing, Grouping and Infectious Disease NAT Screening Market - Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays - Product Thumbnail Image

2024 Japan Blood Typing, Grouping and Infectious Disease NAT Screening Market - Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays

  • Report
  • May 2024
  • Japan
From
2024 Italy Blood Typing, Grouping and Infectious Disease NAT Screening Market - Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays - Product Thumbnail Image

2024 Italy Blood Typing, Grouping and Infectious Disease NAT Screening Market - Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays

  • Report
  • May 2024
  • Italy
From
2024 Germany Blood Typing, Grouping and Infectious Disease NAT Screening Market - 2023 Supplier Shares and Strategies and Strategies, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays - Product Thumbnail Image

2024 Germany Blood Typing, Grouping and Infectious Disease NAT Screening Market - 2023 Supplier Shares and Strategies and Strategies, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays

  • Report
  • May 2024
  • Germany
From
2024 France Blood Typing, Grouping and Infectious Disease NAT Screening Market - Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays - Product Thumbnail Image

2024 France Blood Typing, Grouping and Infectious Disease NAT Screening Market - Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays

  • Report
  • May 2024
  • France
From
2024 Europe Blood Typing, Grouping and Infectious Disease NAT Screening Market - France, Germany, Italy, Spain, UK - Supplier Shares and Strategies by Country, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays - Product Thumbnail Image

2024 Europe Blood Typing, Grouping and Infectious Disease NAT Screening Market - France, Germany, Italy, Spain, UK - Supplier Shares and Strategies by Country, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays

  • Report
  • May 2024
  • Germany, Italy, Spain, ... Germany, Italy, Spain, United Kingdom, Europe, France
From
2024 Global Blood Typing, Grouping and Infectious Disease NAT Screening Market - USA, Europe, Japan - Supplier Shares and Strategies by Country, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays - Product Thumbnail Image

2024 Global Blood Typing, Grouping and Infectious Disease NAT Screening Market - USA, Europe, Japan - Supplier Shares and Strategies by Country, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays

  • Report
  • May 2024
  • Japan, United States, ... Japan, United States, Europe, Global
From
2024 North America Blood Typing, Grouping and Infectious Disease NAT Screening Market - USA, Canada, Mexico - Supplier Shares and Strategies by Country, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays - Product Thumbnail Image

2024 North America Blood Typing, Grouping and Infectious Disease NAT Screening Market - USA, Canada, Mexico - Supplier Shares and Strategies by Country, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays

  • Report
  • May 2024
  • Canada, Mexico, North America Canada, Mexico, North America
From
2024 Middle East Blood Typing, Grouping and Infectious Disease NAT Screening Market - 11 Countries - Supplier Shares and Strategies by Country, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays - Product Thumbnail Image

2024 Middle East Blood Typing, Grouping and Infectious Disease NAT Screening Market - 11 Countries - Supplier Shares and Strategies by Country, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays

  • Report
  • May 2024
  • Middle East
From
2024 Latin America Blood Typing, Grouping and Infectious Disease NAT Screening Market - 22 Countries - Supplier Shares and Strategies by Country, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays - Product Thumbnail Image

2024 Latin America Blood Typing, Grouping and Infectious Disease NAT Screening Market - 22 Countries - Supplier Shares and Strategies by Country, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays

  • Report
  • May 2024
  • Latin America
From
2024 Europe Blood Typing, Grouping and Infectious Disease NAT Screening Market - 38 Countries - Supplier Shares and Strategies by Country, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays - Product Thumbnail Image

2024 Europe Blood Typing, Grouping and Infectious Disease NAT Screening Market - 38 Countries - Supplier Shares and Strategies by Country, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays

  • Report
  • May 2024
  • Europe
From
2024 Asia-Pacific Blood Typing, Grouping and Infectious Disease NAT Screening Market - 18 Countries - Supplier Shares and Strategies by Country, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays - Product Thumbnail Image

2024 Asia-Pacific Blood Typing, Grouping and Infectious Disease NAT Screening Market - 18 Countries - Supplier Shares and Strategies by Country, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays

  • Report
  • May 2024
  • Asia Pacific
From
Loading Indicator